Psyomics, a Cambridge, UK-based healthtech company, raised £2.4M in funding.
Parkwalk was the leader of the round. Meltwind Ventures and Newable Ventures also participated.
The company plans to use the funds for continued expansion of its online mental health assessment platform access to individuals and NHS trusts.
Psyomics was founded by Professor Sabine Bahn, the head of the Cambridge Centre for Neuropsychiatric Research, and Daniel Cowell. They are former COOs of Horizon Discovery. Psyomics develops technology to improve mental health care. Censeo is a digital diagnostic support platform. It replicates the richness and process of a complete face-to–face assessment in a digital format. The user is guided through a series adaptive questions that will help them to create a comprehensive picture of their mental health and concerns. The report includes possible conditions and next steps recommendations. This gives patients an easy way to address any concerns without feeling embarrassed.
The platform can be used in a healthcare setting to support psychiatrists and other clinicians with their decision making. It helps them establish the best care pathway and level for patients faster. The pilot in GP practices was completed last year with positive feedback from patients and GPs. Censeo was then made available to individual users earlier in the year. Additionally, new projects within NHS treatment providers have begun.
Psyomics was founded at the University of Cambridge.